[ad_1] Jakub Porzycki | Nurphoto | Getty Images Pfizer on Wednesday reported first-quarter revenue that beat expectations and hiked its full-year profit outlook, benefiting from […]
Continue readingTag: Health care industry
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
[ad_1] Eli Lilly ‘s raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave little […]
Continue reading
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
[ad_1] Humira, the injectable rheumatoid arthritis treatment is pictured in a pharmacy in Cambridge, Massachusetts. JB Reed | Bloomberg | Getty Images Think a friend […]
Continue reading
Cyberattack on UnitedHealth firm forces doctors to dig into personal savings to stay afloat
[ad_1] Omar Marques | Lightrocket | Getty Images On a Sunday in early March, Dr. Angeli Maun Akey noticed something peculiar while making payroll for […]
Continue reading
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
[ad_1] A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. Lee Smith | Reuters The Federal […]
Continue reading
Jim Cramer says GE Healthcare's unwarranted post-earnings plunge is a buying opportunity
[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour […]
Continue reading
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
[ad_1] Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020. Mike Blake | Reuters Eli […]
Continue reading
Walmart to shutter health centers, virtual care service in latest failed push into health care
[ad_1] Walmart on Tuesday said it will close all of its health-care clinics across the country, a stunning reversal of its plans to bring its […]
Continue reading
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
[ad_1] Jonathan Raa | Nurphoto | Getty Images A federal judge in New Jersey on Monday rejected Johnson & Johnson‘s and Bristol Myers Squibb‘s legal […]
Continue reading
Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum
[ad_1] Eli Lilly appears to be making as much of its popular obesity and diabetes medicines as it can, but shortages are worsening , putting […]
Continue reading